Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jul 2020

Tiwari Manish, Mishra Divya

Abstract excerpt

Novel coronavirus has wrecked medical and health care facilities claiming ∼5% death tollsglobally. All efforts to contain the pathogenesis either using inhibitory drugs or vaccines largelyremained futile due to a lack of better understanding of the genomic feature of this virus. In thepresent study, we compared the 2019-nCoV with other coronaviruses, which indicated that batSARS like coronavirus could be a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Betacoronavirus
Share to Coronavirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronavirus Infections

Share to COVID-19

Share to Drug Design

Share to Pandemics

Share to Pneumonia, Viral

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 32425659
DOI: 10.1016/j.jcv.2020.104441
PMCID: PMC7227581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.PMID 32425659Read ↗

Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug designSemantic proximity Read ↗

Genomic variance of the 2019-nCoV coronavirus.Semantic proximity Read ↗

Genetic Variation and Evolution of the 2019 Novel Coronavirus.Semantic proximity Read ↗

The 2019-new coronavirus epidemic: evidence for virus evolutionSemantic proximity Read ↗

The 2019 novel coronavirus resource.Semantic proximity Read ↗

The 2019‐new coronavirus epidemic: Evidence for virus evolutionSemantic proximity Read ↗

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingSemantic proximity Read ↗

Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin PopulationsSemantic proximity Read ↗

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting WuhanSemantic proximity Read ↗

In silico elucidation revealed SARS CoV and MERS CoV Drug Compounds could be Potential Therapeutic Candidates against Post Fusion Core (S2) Protein of Novel Coronavirus (2019-nCov)Semantic proximity Read ↗

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in ChinaSemantic proximity Read ↗

Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other speciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.